No Picture
business

Fortis Hospital Bannerghatta Road Achieves India’s Fastest Milestone of 3000 Da Vinci Xi Robotic Surgeries

Bengaluru, August 03: Marking a landmark achievement in the evolution of robotic-assisted surgery in India, Fortis Hospital, Bannerghatta Road has become the fastest hospital in the country to complete 3000 robot-assisted surgeries using the advanced Da Vinci Xi surgical system. This milestone reflects the hospital‘s unwavering commitment to clinical excellence, surgical innovation, and delivering superior patient […]

No Picture
business

Kia India Records Best-Ever July Wholesale at 28,200 Units since Market Entry; Registers 27.4 percent Y-o-Y Growth and 16.8 percent YTD Growth

Mumbai, India, 03 August: Kia India, one of the country’s leading mass-premium automakers, today announced wholesale dispatches of 28,200 units in July 2026, registering a robust 27.4% year-on-year growth compared to 22,135 units in July 2025. This marks Kia India‘s best–ever July wholesale performance since its inception.  Further building on the company’s strongest-ever first-half (H1) performance, Kia India recorded cumulative year-to-date (YTD) wholesale dispatches of 191,949 units during the […]

No Picture
business

Maharani Wedding Collections Bags World Record with World’s Largest ‘Saree Pookkalam’

Kochi: Thodupuzha-based Maharani Wedding Collections, a premium wedding textile destination in Kerala, has secured a world record by creating the world’s largest Saree Pookkalam. The record was achieved by creating a 2,000-square-foot Saree Pookkalam – a pookkalam made using sarees instead of the traditional floral arrangement – on the ground floor of Forum Mall, […]

VYLOY (zolbetuximab) in combination with chemotherapy is NOW AVAILABLE and approved for first-line treatment of eligible* adult patients with gastric or gastroesophageal junction adenocarcinoma in India
business

VYLOY (zolbetuximab) in combination with chemotherapy is NOW AVAILABLE and approved for first-line treatment of eligible* adult patients with gastric or gastroesophageal junction adenocarcinoma in India

– VYLOY is the first and only CLDN18.2-targeted treatment approved in the India for adult patients with HER2 negative gastric and gastroesophageal junction (GEJ) adenocarcinoma whose tumors are CLDN18.2 positive – – Central Drugs Standard Control […]